Japan Times: China wanted to show off its vaccines. It’s backfiring.
Tue January, 2021, Age: 3 years
China’s “vaccine diplomacy”, the use of its coronavirus vaccine (primarily that produced by Sinovac), appears to be backfiring or at the very least be beset with problems. Countries, especially those in the developing world, were at first eager to obtain China’s coronavirus vaccines, which unlike their European and U.S. counterparts, can be refrigerated at relatively normal temperatures thus obviating the logistical hurdles imposed by the Pfizer and Moderna vaccines which must be kept at extremely low temperatures. However, numerous countries, including Turkey and Brazil, are encountering delays in receiving the Sinovac vaccine or the components necessary to produce the vaccine domestically. Furthermore, China has been slow to disclose studies related to the vaccines efficacy while a recent study conducted by Brazil revealed an efficacy rate of barely over 50% (the minimum threshold for a vaccine to be considered effective according to the WHO). If China proves unable to speed up its delivery of its vaccines to developing countries or if more studies continue to undercut these vaccines’ effectiveness, China’s “vaccine diplomacy” may redound to its detriment.